nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—SLC22A2—Cladribine—multiple sclerosis	0.188	0.428	CbGbCtD
Memantine—CYP2A6—Prednisolone—multiple sclerosis	0.0962	0.219	CbGbCtD
Memantine—CYP2A6—Dexamethasone—multiple sclerosis	0.0567	0.129	CbGbCtD
Memantine—HTR3A—area postrema—multiple sclerosis	0.0416	0.3	CbGeAlD
Memantine—CYP2C19—Prednisone—multiple sclerosis	0.0376	0.0856	CbGbCtD
Memantine—CYP2B6—Dexamethasone—multiple sclerosis	0.0369	0.0841	CbGbCtD
Memantine—CYP2C19—Dexamethasone—multiple sclerosis	0.0235	0.0535	CbGbCtD
Memantine—GRIN2B—nerve—multiple sclerosis	0.00933	0.0673	CbGeAlD
Memantine—GRIN2A—nerve—multiple sclerosis	0.00815	0.0588	CbGeAlD
Memantine—HTR3A—nerve—multiple sclerosis	0.00541	0.039	CbGeAlD
Memantine—GRIN1—brainstem—multiple sclerosis	0.0042	0.0303	CbGeAlD
Memantine—GRIN2B—brainstem—multiple sclerosis	0.004	0.0289	CbGeAlD
Memantine—GRIN2A—brainstem—multiple sclerosis	0.0035	0.0252	CbGeAlD
Memantine—DRD2—nerve—multiple sclerosis	0.00331	0.0239	CbGeAlD
Memantine—GRIN1—midbrain—multiple sclerosis	0.00267	0.0193	CbGeAlD
Memantine—GRIN1—spinal cord—multiple sclerosis	0.00261	0.0188	CbGeAlD
Memantine—GRIN2B—spinal cord—multiple sclerosis	0.00249	0.018	CbGeAlD
Memantine—GRIN2A—medulla oblongata—multiple sclerosis	0.00244	0.0176	CbGeAlD
Memantine—HTR3A—brainstem—multiple sclerosis	0.00232	0.0167	CbGeAlD
Memantine—GRIN3A—nervous system—multiple sclerosis	0.00232	0.0167	CbGeAlD
Memantine—GRIN3A—central nervous system—multiple sclerosis	0.00223	0.0161	CbGeAlD
Memantine—GRIN2A—midbrain—multiple sclerosis	0.00223	0.0161	CbGeAlD
Memantine—GRIN1—nervous system—multiple sclerosis	0.0022	0.0159	CbGeAlD
Memantine—GRIN2A—spinal cord—multiple sclerosis	0.00218	0.0157	CbGeAlD
Memantine—GRIN1—central nervous system—multiple sclerosis	0.00212	0.0153	CbGeAlD
Memantine—GRIN2B—nervous system—multiple sclerosis	0.0021	0.0151	CbGeAlD
Memantine—GRIN1—cerebellum—multiple sclerosis	0.00207	0.0149	CbGeAlD
Memantine—GRIN2B—central nervous system—multiple sclerosis	0.00202	0.0146	CbGeAlD
Memantine—GRIN2B—cerebellum—multiple sclerosis	0.00197	0.0142	CbGeAlD
Memantine—GRIN2A—nervous system—multiple sclerosis	0.00183	0.0132	CbGeAlD
Memantine—GRIN3A—brain—multiple sclerosis	0.00177	0.0128	CbGeAlD
Memantine—GRIN2A—central nervous system—multiple sclerosis	0.00177	0.0127	CbGeAlD
Memantine—GRIN2A—cerebellum—multiple sclerosis	0.00173	0.0124	CbGeAlD
Memantine—GRIN1—brain—multiple sclerosis	0.00168	0.0121	CbGeAlD
Memantine—GRIN2B—brain—multiple sclerosis	0.0016	0.0116	CbGeAlD
Memantine—DRD2—brainstem—multiple sclerosis	0.00142	0.0102	CbGeAlD
Memantine—GRIN2A—brain—multiple sclerosis	0.0014	0.0101	CbGeAlD
Memantine—DRD2—retina—multiple sclerosis	0.00137	0.00988	CbGeAlD
Memantine—HTR3A—nervous system—multiple sclerosis	0.00122	0.00877	CbGeAlD
Memantine—HTR3A—central nervous system—multiple sclerosis	0.00117	0.00844	CbGeAlD
Memantine—CYP2A6—cerebellum—multiple sclerosis	0.00112	0.00811	CbGeAlD
Memantine—HTR3A—brain—multiple sclerosis	0.000929	0.0067	CbGeAlD
Memantine—CYP2A6—brain—multiple sclerosis	0.000913	0.00659	CbGeAlD
Memantine—DRD2—midbrain—multiple sclerosis	0.000905	0.00653	CbGeAlD
Memantine—DRD2—nervous system—multiple sclerosis	0.000744	0.00537	CbGeAlD
Memantine—DRD2—central nervous system—multiple sclerosis	0.000716	0.00517	CbGeAlD
Memantine—DRD2—cerebellum—multiple sclerosis	0.0007	0.00505	CbGeAlD
Memantine—CYP2B6—nervous system—multiple sclerosis	0.000601	0.00434	CbGeAlD
Memantine—CYP2B6—central nervous system—multiple sclerosis	0.000579	0.00418	CbGeAlD
Memantine—DRD2—brain—multiple sclerosis	0.000568	0.0041	CbGeAlD
Memantine—CYP2B6—brain—multiple sclerosis	0.00046	0.00332	CbGeAlD
Memantine—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000206	0.00282	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—BCHE—multiple sclerosis	0.000204	0.00279	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000203	0.00278	CbGpPWpGaD
Memantine—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000203	0.00278	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—RGS1—multiple sclerosis	0.000202	0.00276	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.0002	0.00274	CbGpPWpGaD
Memantine—GRIN2A—Alzheimers Disease—MAPK1—multiple sclerosis	0.000193	0.00263	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—PTPRC—multiple sclerosis	0.000191	0.0026	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—S1PR1—multiple sclerosis	0.000189	0.00259	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—PTPRC—multiple sclerosis	0.000186	0.00254	CbGpPWpGaD
Memantine—GRIN2A—Alzheimers Disease—TNF—multiple sclerosis	0.000183	0.0025	CbGpPWpGaD
Memantine—GRIN1—EPH-Ephrin signaling—MMP9—multiple sclerosis	0.000181	0.00247	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—IFNG—multiple sclerosis	0.000179	0.00245	CbGpPWpGaD
Memantine—DRD2—GPCRs, Class A Rhodopsin-like—GPR65—multiple sclerosis	0.000178	0.00243	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000177	0.00242	CbGpPWpGaD
Memantine—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000177	0.00241	CbGpPWpGaD
Memantine—GRIN2B—EPH-Ephrin signaling—MMP9—multiple sclerosis	0.000176	0.00241	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—CCR1—multiple sclerosis	0.000176	0.0024	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—CXCL13—multiple sclerosis	0.000176	0.0024	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—PRNP—multiple sclerosis	0.000175	0.00239	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—PRNP—multiple sclerosis	0.000171	0.00233	CbGpPWpGaD
Memantine—GRIN1—Alzheimers Disease—MAPK1—multiple sclerosis	0.000168	0.00229	CbGpPWpGaD
Memantine—GRIN2B—Alzheimers Disease—MAPK1—multiple sclerosis	0.000164	0.00224	CbGpPWpGaD
Memantine—DRD2—GPCRs, Class A Rhodopsin-like—CCR1—multiple sclerosis	0.000163	0.00222	CbGpPWpGaD
Memantine—GRIN1—Alzheimers Disease—TNF—multiple sclerosis	0.00016	0.00218	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—IL1B—multiple sclerosis	0.00016	0.00218	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—IL2—multiple sclerosis	0.000159	0.00218	CbGpPWpGaD
Memantine—DRD2—Hypothetical Network for Drug Addiction—MAPK1—multiple sclerosis	0.000159	0.00217	CbGpPWpGaD
Memantine—GRIN2B—Alzheimers Disease—TNF—multiple sclerosis	0.000156	0.00213	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000154	0.0021	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—GPR65—multiple sclerosis	0.000153	0.00208	CbGpPWpGaD
Memantine—SLC22A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000151	0.00206	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—MMP9—multiple sclerosis	0.000151	0.00206	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000145	0.00198	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—S1PR1—multiple sclerosis	0.000144	0.00197	CbGpPWpGaD
Memantine—CYP2A6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000143	0.00196	CbGpPWpGaD
Memantine—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000143	0.00195	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000142	0.00194	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR1—multiple sclerosis	0.00014	0.00191	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL13—multiple sclerosis	0.00014	0.00191	CbGpPWpGaD
Memantine—Loss of consciousness—Betamethasone—multiple sclerosis	0.000139	0.000399	CcSEcCtD
Memantine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000139	0.000399	CcSEcCtD
Memantine—Epistaxis—Methotrexate—multiple sclerosis	0.000139	0.000399	CcSEcCtD
Memantine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000139	0.000399	CcSEcCtD
Memantine—Paraesthesia—Prednisolone—multiple sclerosis	0.000139	0.000399	CcSEcCtD
Memantine—Tachycardia—Triamcinolone—multiple sclerosis	0.000139	0.000399	CcSEcCtD
Memantine—Mental disorder—Prednisone—multiple sclerosis	0.000139	0.000398	CcSEcCtD
Memantine—Nausea—Azathioprine—multiple sclerosis	0.000139	0.000398	CcSEcCtD
Memantine—Tachycardia—Methylprednisolone—multiple sclerosis	0.000139	0.000398	CcSEcCtD
Memantine—Skin disorder—Methylprednisolone—multiple sclerosis	0.000138	0.000396	CcSEcCtD
Memantine—Malnutrition—Prednisone—multiple sclerosis	0.000138	0.000396	CcSEcCtD
Memantine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000138	0.000395	CcSEcCtD
Memantine—Agranulocytosis—Methotrexate—multiple sclerosis	0.000138	0.000395	CcSEcCtD
Memantine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000138	0.000394	CcSEcCtD
Memantine—Convulsion—Betamethasone—multiple sclerosis	0.000137	0.000394	CcSEcCtD
Memantine—Convulsion—Dexamethasone—multiple sclerosis	0.000137	0.000394	CcSEcCtD
Memantine—Hypertension—Betamethasone—multiple sclerosis	0.000137	0.000392	CcSEcCtD
Memantine—Hypertension—Dexamethasone—multiple sclerosis	0.000137	0.000392	CcSEcCtD
Memantine—GRIN1—Developmental Biology—PTPRC—multiple sclerosis	0.000136	0.00186	CbGpPWpGaD
Memantine—Asthenia—Mitoxantrone—multiple sclerosis	0.000136	0.000389	CcSEcCtD
Memantine—Myalgia—Betamethasone—multiple sclerosis	0.000135	0.000387	CcSEcCtD
Memantine—Myalgia—Dexamethasone—multiple sclerosis	0.000135	0.000387	CcSEcCtD
Memantine—Anxiety—Dexamethasone—multiple sclerosis	0.000135	0.000385	CcSEcCtD
Memantine—Anxiety—Betamethasone—multiple sclerosis	0.000135	0.000385	CcSEcCtD
Memantine—Discomfort—Betamethasone—multiple sclerosis	0.000133	0.000382	CcSEcCtD
Memantine—Discomfort—Dexamethasone—multiple sclerosis	0.000133	0.000382	CcSEcCtD
Memantine—Haemoglobin—Methotrexate—multiple sclerosis	0.000133	0.000382	CcSEcCtD
Memantine—Hypotension—Methylprednisolone—multiple sclerosis	0.000133	0.000381	CcSEcCtD
Memantine—GRIN2B—Developmental Biology—PTPRC—multiple sclerosis	0.000133	0.00181	CbGpPWpGaD
Memantine—Pain—Prednisolone—multiple sclerosis	0.000133	0.00038	CcSEcCtD
Memantine—Hepatitis—Methotrexate—multiple sclerosis	0.000133	0.00038	CcSEcCtD
Memantine—Haemorrhage—Methotrexate—multiple sclerosis	0.000133	0.00038	CcSEcCtD
Memantine—Pharyngitis—Methotrexate—multiple sclerosis	0.000132	0.000377	CcSEcCtD
Memantine—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000131	0.000375	CcSEcCtD
Memantine—Vision blurred—Prednisone—multiple sclerosis	0.00013	0.000373	CcSEcCtD
Memantine—Urethral disorder—Methotrexate—multiple sclerosis	0.00013	0.000372	CcSEcCtD
Memantine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.00013	0.000372	CcSEcCtD
Memantine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.00013	0.000371	CcSEcCtD
Memantine—Oedema—Betamethasone—multiple sclerosis	0.000129	0.000371	CcSEcCtD
Memantine—Oedema—Dexamethasone—multiple sclerosis	0.000129	0.000371	CcSEcCtD
Memantine—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000129	0.00037	CcSEcCtD
Memantine—Insomnia—Triamcinolone—multiple sclerosis	0.000129	0.00037	CcSEcCtD
Memantine—Insomnia—Methylprednisolone—multiple sclerosis	0.000129	0.000369	CcSEcCtD
Memantine—Infection—Dexamethasone—multiple sclerosis	0.000129	0.000368	CcSEcCtD
Memantine—Infection—Betamethasone—multiple sclerosis	0.000129	0.000368	CcSEcCtD
Memantine—Ill-defined disorder—Prednisone—multiple sclerosis	0.000128	0.000367	CcSEcCtD
Memantine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000128	0.000367	CcSEcCtD
Memantine—GRIN1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000128	0.00175	CbGpPWpGaD
Memantine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000128	0.000366	CcSEcCtD
Memantine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000128	0.000366	CcSEcCtD
Memantine—Visual impairment—Methotrexate—multiple sclerosis	0.000128	0.000366	CcSEcCtD
Memantine—Anaemia—Prednisone—multiple sclerosis	0.000128	0.000366	CcSEcCtD
Memantine—Shock—Dexamethasone—multiple sclerosis	0.000127	0.000365	CcSEcCtD
Memantine—Shock—Betamethasone—multiple sclerosis	0.000127	0.000365	CcSEcCtD
Memantine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000127	0.000364	CcSEcCtD
Memantine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000127	0.000364	CcSEcCtD
Memantine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000127	0.000364	CcSEcCtD
Memantine—Agitation—Prednisone—multiple sclerosis	0.000127	0.000363	CcSEcCtD
Memantine—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000127	0.000363	CcSEcCtD
Memantine—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000127	0.000363	CcSEcCtD
Memantine—Tachycardia—Dexamethasone—multiple sclerosis	0.000126	0.000362	CcSEcCtD
Memantine—Tachycardia—Betamethasone—multiple sclerosis	0.000126	0.000362	CcSEcCtD
Memantine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000126	0.00036	CcSEcCtD
Memantine—Erythema multiforme—Methotrexate—multiple sclerosis	0.000125	0.000359	CcSEcCtD
Memantine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000125	0.000359	CcSEcCtD
Memantine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000125	0.000358	CcSEcCtD
Memantine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000125	0.000358	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—MYC—multiple sclerosis	0.000125	0.0017	CbGpPWpGaD
Memantine—Malaise—Prednisone—multiple sclerosis	0.000125	0.000357	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—TGFB1—multiple sclerosis	0.000124	0.0017	CbGpPWpGaD
Memantine—Vertigo—Prednisone—multiple sclerosis	0.000124	0.000355	CcSEcCtD
Memantine—Eye disorder—Methotrexate—multiple sclerosis	0.000124	0.000355	CcSEcCtD
Memantine—Syncope—Prednisone—multiple sclerosis	0.000124	0.000355	CcSEcCtD
Memantine—Tinnitus—Methotrexate—multiple sclerosis	0.000124	0.000354	CcSEcCtD
Memantine—Anorexia—Dexamethasone—multiple sclerosis	0.000123	0.000353	CcSEcCtD
Memantine—Anorexia—Betamethasone—multiple sclerosis	0.000123	0.000353	CcSEcCtD
Memantine—Urticaria—Prednisolone—multiple sclerosis	0.000123	0.000353	CcSEcCtD
Memantine—Cardiac disorder—Methotrexate—multiple sclerosis	0.000123	0.000352	CcSEcCtD
Memantine—Fatigue—Triamcinolone—multiple sclerosis	0.000123	0.000352	CcSEcCtD
Memantine—Fatigue—Methylprednisolone—multiple sclerosis	0.000123	0.000351	CcSEcCtD
Memantine—Pain—Triamcinolone—multiple sclerosis	0.000122	0.000349	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—MAPK1—multiple sclerosis	0.000122	0.00166	CbGpPWpGaD
Memantine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000122	0.00166	CbGpPWpGaD
Memantine—Loss of consciousness—Prednisone—multiple sclerosis	0.000121	0.000348	CcSEcCtD
Memantine—Hypotension—Dexamethasone—multiple sclerosis	0.000121	0.000346	CcSEcCtD
Memantine—Hypotension—Betamethasone—multiple sclerosis	0.000121	0.000346	CcSEcCtD
Memantine—Angiopathy—Methotrexate—multiple sclerosis	0.00012	0.000345	CcSEcCtD
Memantine—Vomiting—Mitoxantrone—multiple sclerosis	0.00012	0.000344	CcSEcCtD
Memantine—Immune system disorder—Methotrexate—multiple sclerosis	0.00012	0.000343	CcSEcCtD
Memantine—Convulsion—Prednisone—multiple sclerosis	0.00012	0.000343	CcSEcCtD
Memantine—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000119	0.000342	CcSEcCtD
Memantine—Hypertension—Prednisone—multiple sclerosis	0.000119	0.000342	CcSEcCtD
Memantine—Rash—Mitoxantrone—multiple sclerosis	0.000119	0.000341	CcSEcCtD
Memantine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000119	0.000341	CcSEcCtD
Memantine—Chills—Methotrexate—multiple sclerosis	0.000119	0.000341	CcSEcCtD
Memantine—Headache—Mitoxantrone—multiple sclerosis	0.000118	0.000339	CcSEcCtD
Memantine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000118	0.000338	CcSEcCtD
Memantine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000118	0.000338	CcSEcCtD
Memantine—Arthralgia—Prednisone—multiple sclerosis	0.000118	0.000337	CcSEcCtD
Memantine—Myalgia—Prednisone—multiple sclerosis	0.000118	0.000337	CcSEcCtD
Memantine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000118	0.000337	CcSEcCtD
Memantine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000117	0.000336	CcSEcCtD
Memantine—Anxiety—Prednisone—multiple sclerosis	0.000117	0.000336	CcSEcCtD
Memantine—Alopecia—Methotrexate—multiple sclerosis	0.000117	0.000336	CcSEcCtD
Memantine—Insomnia—Betamethasone—multiple sclerosis	0.000117	0.000335	CcSEcCtD
Memantine—Insomnia—Dexamethasone—multiple sclerosis	0.000117	0.000335	CcSEcCtD
Memantine—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000116	0.000333	CcSEcCtD
Memantine—DRD2—G alpha (i) signalling events—CXCR3—multiple sclerosis	0.000116	0.00159	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—GPR65—multiple sclerosis	0.000116	0.00159	CbGpPWpGaD
Memantine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000116	0.000333	CcSEcCtD
Memantine—Paraesthesia—Betamethasone—multiple sclerosis	0.000116	0.000333	CcSEcCtD
Memantine—Discomfort—Prednisone—multiple sclerosis	0.000116	0.000333	CcSEcCtD
Memantine—Mental disorder—Methotrexate—multiple sclerosis	0.000116	0.000333	CcSEcCtD
Memantine—GRIN1—Spinal Cord Injury—TNF—multiple sclerosis	0.000116	0.00158	CbGpPWpGaD
Memantine—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000116	0.00158	CbGpPWpGaD
Memantine—Malnutrition—Methotrexate—multiple sclerosis	0.000115	0.000331	CcSEcCtD
Memantine—GRIN1—BDNF signaling pathway—STAT3—multiple sclerosis	0.000114	0.00156	CbGpPWpGaD
Memantine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000114	0.000327	CcSEcCtD
Memantine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000114	0.000326	CcSEcCtD
Memantine—Dyspepsia—Betamethasone—multiple sclerosis	0.000114	0.000326	CcSEcCtD
Memantine—Urticaria—Triamcinolone—multiple sclerosis	0.000113	0.000325	CcSEcCtD
Memantine—DRD2—G alpha (i) signalling events—CCR2—multiple sclerosis	0.000113	0.00154	CbGpPWpGaD
Memantine—Urticaria—Methylprednisolone—multiple sclerosis	0.000113	0.000324	CcSEcCtD
Memantine—Dysgeusia—Methotrexate—multiple sclerosis	0.000113	0.000324	CcSEcCtD
Memantine—Body temperature increased—Triamcinolone—multiple sclerosis	0.000113	0.000323	CcSEcCtD
Memantine—Oedema—Prednisone—multiple sclerosis	0.000113	0.000323	CcSEcCtD
Memantine—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000112	0.000322	CcSEcCtD
Memantine—Decreased appetite—Betamethasone—multiple sclerosis	0.000112	0.000322	CcSEcCtD
Memantine—Decreased appetite—Dexamethasone—multiple sclerosis	0.000112	0.000322	CcSEcCtD
Memantine—Nausea—Mitoxantrone—multiple sclerosis	0.000112	0.000322	CcSEcCtD
Memantine—Infection—Prednisone—multiple sclerosis	0.000112	0.000321	CcSEcCtD
Memantine—DRD2—GPCRs, Class A Rhodopsin-like—PTGER4—multiple sclerosis	0.000112	0.00153	CbGpPWpGaD
Memantine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000112	0.00032	CcSEcCtD
Memantine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000112	0.00032	CcSEcCtD
Memantine—Back pain—Methotrexate—multiple sclerosis	0.000112	0.00032	CcSEcCtD
Memantine—Fatigue—Betamethasone—multiple sclerosis	0.000112	0.00032	CcSEcCtD
Memantine—Fatigue—Dexamethasone—multiple sclerosis	0.000112	0.00032	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000112	0.00152	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—STAT3—multiple sclerosis	0.000111	0.00152	CbGpPWpGaD
Memantine—Shock—Prednisone—multiple sclerosis	0.000111	0.000318	CcSEcCtD
Memantine—Pain—Betamethasone—multiple sclerosis	0.000111	0.000317	CcSEcCtD
Memantine—Pain—Dexamethasone—multiple sclerosis	0.000111	0.000317	CcSEcCtD
Memantine—Nervous system disorder—Prednisone—multiple sclerosis	0.000111	0.000317	CcSEcCtD
Memantine—Tachycardia—Prednisone—multiple sclerosis	0.00011	0.000315	CcSEcCtD
Memantine—SLC22A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.00011	0.0015	CbGpPWpGaD
Memantine—Skin disorder—Prednisone—multiple sclerosis	0.000109	0.000314	CcSEcCtD
Memantine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000109	0.000312	CcSEcCtD
Memantine—SLC22A2—Neuronal System—BCHE—multiple sclerosis	0.000109	0.00149	CbGpPWpGaD
Memantine—Vision blurred—Methotrexate—multiple sclerosis	0.000109	0.000312	CcSEcCtD
Memantine—DRD2—GPCRs, Class A Rhodopsin-like—CXCR3—multiple sclerosis	0.000108	0.00147	CbGpPWpGaD
Memantine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000108	0.00147	CbGpPWpGaD
Memantine—Anorexia—Prednisone—multiple sclerosis	0.000107	0.000308	CcSEcCtD
Memantine—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000107	0.000307	CcSEcCtD
Memantine—Anaemia—Methotrexate—multiple sclerosis	0.000107	0.000306	CcSEcCtD
Memantine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000107	0.000305	CcSEcCtD
Memantine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000107	0.000305	CcSEcCtD
Memantine—DRD2—GPCR ligand binding—CXCL13—multiple sclerosis	0.000106	0.00145	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CCR1—multiple sclerosis	0.000106	0.00145	CbGpPWpGaD
Memantine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000106	0.00145	CbGpPWpGaD
Memantine—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000106	0.000303	CcSEcCtD
Memantine—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000106	0.000303	CcSEcCtD
Memantine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000105	0.000301	CcSEcCtD
Memantine—DRD2—GPCRs, Class A Rhodopsin-like—CCR2—multiple sclerosis	0.000105	0.00143	CbGpPWpGaD
Memantine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000105	0.0003	CcSEcCtD
Memantine—DRD2—G alpha (i) signalling events—CNR1—multiple sclerosis	0.000104	0.00143	CbGpPWpGaD
Memantine—Malaise—Methotrexate—multiple sclerosis	0.000104	0.000298	CcSEcCtD
Memantine—GRIN1—BDNF signaling pathway—MAPK1—multiple sclerosis	0.000104	0.00142	CbGpPWpGaD
Memantine—Vertigo—Methotrexate—multiple sclerosis	0.000104	0.000297	CcSEcCtD
Memantine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	0.000104	0.00141	CbGpPWpGaD
Memantine—Leukopenia—Methotrexate—multiple sclerosis	0.000103	0.000296	CcSEcCtD
Memantine—Urticaria—Dexamethasone—multiple sclerosis	0.000103	0.000294	CcSEcCtD
Memantine—Urticaria—Betamethasone—multiple sclerosis	0.000103	0.000294	CcSEcCtD
Memantine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000103	0.000294	CcSEcCtD
Memantine—Dizziness—Prednisolone—multiple sclerosis	0.000103	0.000294	CcSEcCtD
Memantine—Asthenia—Triamcinolone—multiple sclerosis	0.000102	0.000293	CcSEcCtD
Memantine—Abdominal pain—Betamethasone—multiple sclerosis	0.000102	0.000293	CcSEcCtD
Memantine—Abdominal pain—Dexamethasone—multiple sclerosis	0.000102	0.000293	CcSEcCtD
Memantine—Body temperature increased—Betamethasone—multiple sclerosis	0.000102	0.000293	CcSEcCtD
Memantine—Body temperature increased—Dexamethasone—multiple sclerosis	0.000102	0.000293	CcSEcCtD
Memantine—Asthenia—Methylprednisolone—multiple sclerosis	0.000102	0.000292	CcSEcCtD
Memantine—Insomnia—Prednisone—multiple sclerosis	0.000102	0.000292	CcSEcCtD
Memantine—GRIN2B—BDNF signaling pathway—MAPK1—multiple sclerosis	0.000101	0.00138	CbGpPWpGaD
Memantine—Paraesthesia—Prednisone—multiple sclerosis	0.000101	0.00029	CcSEcCtD
Memantine—Pruritus—Triamcinolone—multiple sclerosis	0.000101	0.000289	CcSEcCtD
Memantine—Cough—Methotrexate—multiple sclerosis	0.000101	0.000288	CcSEcCtD
Memantine—Pruritus—Methylprednisolone—multiple sclerosis	0.000101	0.000288	CcSEcCtD
Memantine—Convulsion—Methotrexate—multiple sclerosis	0.0001	0.000286	CcSEcCtD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL3—multiple sclerosis	9.95e-05	0.00136	CbGpPWpGaD
Memantine—Dyspepsia—Prednisone—multiple sclerosis	9.92e-05	0.000284	CcSEcCtD
Memantine—Myalgia—Methotrexate—multiple sclerosis	9.83e-05	0.000281	CcSEcCtD
Memantine—Arthralgia—Methotrexate—multiple sclerosis	9.83e-05	0.000281	CcSEcCtD
Memantine—Chest pain—Methotrexate—multiple sclerosis	9.83e-05	0.000281	CcSEcCtD
Memantine—Decreased appetite—Prednisone—multiple sclerosis	9.8e-05	0.000281	CcSEcCtD
Memantine—Rash—Prednisolone—multiple sclerosis	9.78e-05	0.00028	CcSEcCtD
Memantine—Dermatitis—Prednisolone—multiple sclerosis	9.77e-05	0.00028	CcSEcCtD
Memantine—Diarrhoea—Methylprednisolone—multiple sclerosis	9.74e-05	0.000279	CcSEcCtD
Memantine—Fatigue—Prednisone—multiple sclerosis	9.72e-05	0.000278	CcSEcCtD
Memantine—Headache—Prednisolone—multiple sclerosis	9.72e-05	0.000278	CcSEcCtD
Memantine—Discomfort—Methotrexate—multiple sclerosis	9.71e-05	0.000278	CcSEcCtD
Memantine—DRD2—GPCRs, Class A Rhodopsin-like—CNR1—multiple sclerosis	9.69e-05	0.00132	CbGpPWpGaD
Memantine—Constipation—Prednisone—multiple sclerosis	9.64e-05	0.000276	CcSEcCtD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—PTGER4—multiple sclerosis	9.57e-05	0.00131	CbGpPWpGaD
Memantine—Confusional state—Methotrexate—multiple sclerosis	9.5e-05	0.000272	CcSEcCtD
Memantine—Dizziness—Triamcinolone—multiple sclerosis	9.43e-05	0.00027	CcSEcCtD
Memantine—Dizziness—Methylprednisolone—multiple sclerosis	9.41e-05	0.00027	CcSEcCtD
Memantine—DRD2—G alpha (i) signalling events—CXCL10—multiple sclerosis	9.4e-05	0.00128	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—IL6—multiple sclerosis	9.36e-05	0.00128	CbGpPWpGaD
Memantine—Infection—Methotrexate—multiple sclerosis	9.36e-05	0.000268	CcSEcCtD
Memantine—Feeling abnormal—Prednisone—multiple sclerosis	9.29e-05	0.000266	CcSEcCtD
Memantine—Asthenia—Dexamethasone—multiple sclerosis	9.29e-05	0.000266	CcSEcCtD
Memantine—Asthenia—Betamethasone—multiple sclerosis	9.29e-05	0.000266	CcSEcCtD
Memantine—GRIN1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	9.28e-05	0.00127	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCR3—multiple sclerosis	9.25e-05	0.00126	CbGpPWpGaD
Memantine—Nervous system disorder—Methotrexate—multiple sclerosis	9.24e-05	0.000265	CcSEcCtD
Memantine—Thrombocytopenia—Methotrexate—multiple sclerosis	9.22e-05	0.000264	CcSEcCtD
Memantine—Gastrointestinal pain—Prednisone—multiple sclerosis	9.22e-05	0.000264	CcSEcCtD
Memantine—Nausea—Prednisolone—multiple sclerosis	9.21e-05	0.000264	CcSEcCtD
Memantine—GRIN2A—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	9.16e-05	0.00125	CbGpPWpGaD
Memantine—Pruritus—Dexamethasone—multiple sclerosis	9.16e-05	0.000262	CcSEcCtD
Memantine—Pruritus—Betamethasone—multiple sclerosis	9.16e-05	0.000262	CcSEcCtD
Memantine—Skin disorder—Methotrexate—multiple sclerosis	9.15e-05	0.000262	CcSEcCtD
Memantine—Hyperhidrosis—Methotrexate—multiple sclerosis	9.11e-05	0.000261	CcSEcCtD
Memantine—Vomiting—Triamcinolone—multiple sclerosis	9.07e-05	0.00026	CcSEcCtD
Memantine—Vomiting—Methylprednisolone—multiple sclerosis	9.05e-05	0.000259	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	9e-05	0.00123	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR2—multiple sclerosis	8.99e-05	0.00123	CbGpPWpGaD
Memantine—Rash—Triamcinolone—multiple sclerosis	8.99e-05	0.000258	CcSEcCtD
Memantine—Dermatitis—Triamcinolone—multiple sclerosis	8.98e-05	0.000257	CcSEcCtD
Memantine—Anorexia—Methotrexate—multiple sclerosis	8.98e-05	0.000257	CcSEcCtD
Memantine—Rash—Methylprednisolone—multiple sclerosis	8.97e-05	0.000257	CcSEcCtD
Memantine—Dermatitis—Methylprednisolone—multiple sclerosis	8.96e-05	0.000257	CcSEcCtD
Memantine—Urticaria—Prednisone—multiple sclerosis	8.95e-05	0.000256	CcSEcCtD
Memantine—SLC22A2—Metabolism—SRM—multiple sclerosis	8.94e-05	0.00122	CbGpPWpGaD
Memantine—Headache—Triamcinolone—multiple sclerosis	8.94e-05	0.000256	CcSEcCtD
Memantine—Headache—Methylprednisolone—multiple sclerosis	8.92e-05	0.000255	CcSEcCtD
Memantine—Abdominal pain—Prednisone—multiple sclerosis	8.91e-05	0.000255	CcSEcCtD
Memantine—Body temperature increased—Prednisone—multiple sclerosis	8.91e-05	0.000255	CcSEcCtD
Memantine—Diarrhoea—Dexamethasone—multiple sclerosis	8.85e-05	0.000254	CcSEcCtD
Memantine—Diarrhoea—Betamethasone—multiple sclerosis	8.85e-05	0.000254	CcSEcCtD
Memantine—Hypotension—Methotrexate—multiple sclerosis	8.8e-05	0.000252	CcSEcCtD
Memantine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.73e-05	0.00119	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	8.67e-05	0.00118	CbGpPWpGaD
Memantine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	8.58e-05	0.000246	CcSEcCtD
Memantine—Dizziness—Betamethasone—multiple sclerosis	8.56e-05	0.000245	CcSEcCtD
Memantine—Dizziness—Dexamethasone—multiple sclerosis	8.56e-05	0.000245	CcSEcCtD
Memantine—GRIN1—Axon guidance—TYK2—multiple sclerosis	8.53e-05	0.00117	CbGpPWpGaD
Memantine—Insomnia—Methotrexate—multiple sclerosis	8.52e-05	0.000244	CcSEcCtD
Memantine—Nausea—Triamcinolone—multiple sclerosis	8.47e-05	0.000243	CcSEcCtD
Memantine—Paraesthesia—Methotrexate—multiple sclerosis	8.46e-05	0.000242	CcSEcCtD
Memantine—Nausea—Methylprednisolone—multiple sclerosis	8.45e-05	0.000242	CcSEcCtD
Memantine—Dyspnoea—Methotrexate—multiple sclerosis	8.4e-05	0.000241	CcSEcCtD
Memantine—Somnolence—Methotrexate—multiple sclerosis	8.37e-05	0.00024	CcSEcCtD
Memantine—GRIN2B—Axon guidance—TYK2—multiple sclerosis	8.32e-05	0.00114	CbGpPWpGaD
Memantine—Hypersensitivity—Prednisone—multiple sclerosis	8.3e-05	0.000238	CcSEcCtD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	8.3e-05	0.00113	CbGpPWpGaD
Memantine—Dyspepsia—Methotrexate—multiple sclerosis	8.29e-05	0.000237	CcSEcCtD
Memantine—Vomiting—Betamethasone—multiple sclerosis	8.23e-05	0.000236	CcSEcCtD
Memantine—Vomiting—Dexamethasone—multiple sclerosis	8.23e-05	0.000236	CcSEcCtD
Memantine—CYP2A6—Metabolism—SRM—multiple sclerosis	8.21e-05	0.00112	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—FAS—multiple sclerosis	8.19e-05	0.00112	CbGpPWpGaD
Memantine—Decreased appetite—Methotrexate—multiple sclerosis	8.19e-05	0.000235	CcSEcCtD
Memantine—Rash—Betamethasone—multiple sclerosis	8.16e-05	0.000234	CcSEcCtD
Memantine—Rash—Dexamethasone—multiple sclerosis	8.16e-05	0.000234	CcSEcCtD
Memantine—Dermatitis—Betamethasone—multiple sclerosis	8.15e-05	0.000234	CcSEcCtD
Memantine—Dermatitis—Dexamethasone—multiple sclerosis	8.15e-05	0.000234	CcSEcCtD
Memantine—DRD2—GPCR downstream signaling—S1PR1—multiple sclerosis	8.15e-05	0.00111	CbGpPWpGaD
Memantine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	8.13e-05	0.000233	CcSEcCtD
Memantine—Fatigue—Methotrexate—multiple sclerosis	8.12e-05	0.000233	CcSEcCtD
Memantine—Headache—Dexamethasone—multiple sclerosis	8.11e-05	0.000232	CcSEcCtD
Memantine—Headache—Betamethasone—multiple sclerosis	8.11e-05	0.000232	CcSEcCtD
Memantine—DRD2—G alpha (i) signalling events—CCL5—multiple sclerosis	8.09e-05	0.0011	CbGpPWpGaD
Memantine—Asthenia—Prednisone—multiple sclerosis	8.09e-05	0.000232	CcSEcCtD
Memantine—Pain—Methotrexate—multiple sclerosis	8.05e-05	0.000231	CcSEcCtD
Memantine—GRIN1—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	7.99e-05	0.00109	CbGpPWpGaD
Memantine—Pruritus—Prednisone—multiple sclerosis	7.97e-05	0.000228	CcSEcCtD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.92e-05	0.00108	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.92e-05	0.00108	CbGpPWpGaD
Memantine—GRIN2B—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	7.79e-05	0.00106	CbGpPWpGaD
Memantine—Feeling abnormal—Methotrexate—multiple sclerosis	7.76e-05	0.000222	CcSEcCtD
Memantine—Diarrhoea—Prednisone—multiple sclerosis	7.71e-05	0.000221	CcSEcCtD
Memantine—Gastrointestinal pain—Methotrexate—multiple sclerosis	7.7e-05	0.000221	CcSEcCtD
Memantine—Nausea—Betamethasone—multiple sclerosis	7.69e-05	0.00022	CcSEcCtD
Memantine—Nausea—Dexamethasone—multiple sclerosis	7.69e-05	0.00022	CcSEcCtD
Memantine—SLC22A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	7.66e-05	0.00105	CbGpPWpGaD
Memantine—CYP2A6—Biological oxidations—POMC—multiple sclerosis	7.61e-05	0.00104	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CCL3—multiple sclerosis	7.57e-05	0.00103	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	7.49e-05	0.00102	CbGpPWpGaD
Memantine—Urticaria—Methotrexate—multiple sclerosis	7.48e-05	0.000214	CcSEcCtD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	7.47e-05	0.00102	CbGpPWpGaD
Memantine—Dizziness—Prednisone—multiple sclerosis	7.45e-05	0.000213	CcSEcCtD
Memantine—Abdominal pain—Methotrexate—multiple sclerosis	7.45e-05	0.000213	CcSEcCtD
Memantine—Body temperature increased—Methotrexate—multiple sclerosis	7.45e-05	0.000213	CcSEcCtD
Memantine—DRD2—Signaling by GPCR—S1PR1—multiple sclerosis	7.4e-05	0.00101	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—PTGER4—multiple sclerosis	7.29e-05	0.000995	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—CCR5—multiple sclerosis	7.29e-05	0.000995	CbGpPWpGaD
Memantine—Vomiting—Prednisone—multiple sclerosis	7.17e-05	0.000205	CcSEcCtD
Memantine—Rash—Prednisone—multiple sclerosis	7.11e-05	0.000204	CcSEcCtD
Memantine—Dermatitis—Prednisone—multiple sclerosis	7.1e-05	0.000203	CcSEcCtD
Memantine—Headache—Prednisone—multiple sclerosis	7.06e-05	0.000202	CcSEcCtD
Memantine—DRD2—GPCR ligand binding—CXCR3—multiple sclerosis	7.04e-05	0.000961	CbGpPWpGaD
Memantine—GRIN2A—Neuronal System—MAPK1—multiple sclerosis	7.02e-05	0.000958	CbGpPWpGaD
Memantine—Hypersensitivity—Methotrexate—multiple sclerosis	6.94e-05	0.000199	CcSEcCtD
Memantine—DRD2—GPCR downstream signaling—RGS1—multiple sclerosis	6.93e-05	0.000946	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CCR2—multiple sclerosis	6.85e-05	0.000935	CbGpPWpGaD
Memantine—DRD2—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	6.76e-05	0.000924	CbGpPWpGaD
Memantine—Asthenia—Methotrexate—multiple sclerosis	6.76e-05	0.000194	CcSEcCtD
Memantine—GRIN1—Axon guidance—MMP9—multiple sclerosis	6.72e-05	0.000918	CbGpPWpGaD
Memantine—Nausea—Prednisone—multiple sclerosis	6.69e-05	0.000192	CcSEcCtD
Memantine—Pruritus—Methotrexate—multiple sclerosis	6.66e-05	0.000191	CcSEcCtD
Memantine—CYP2B6—Metabolism—SRM—multiple sclerosis	6.62e-05	0.000904	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—GPR65—multiple sclerosis	6.57e-05	0.000897	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—MMP9—multiple sclerosis	6.55e-05	0.000894	CbGpPWpGaD
Memantine—Diarrhoea—Methotrexate—multiple sclerosis	6.44e-05	0.000185	CcSEcCtD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	6.43e-05	0.000878	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—ALB—multiple sclerosis	6.38e-05	0.000871	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CNR1—multiple sclerosis	6.32e-05	0.000863	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP24A1—multiple sclerosis	6.3e-05	0.00086	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—CYP27B1—multiple sclerosis	6.3e-05	0.00086	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—RGS1—multiple sclerosis	6.29e-05	0.000859	CbGpPWpGaD
Memantine—Dizziness—Methotrexate—multiple sclerosis	6.23e-05	0.000178	CcSEcCtD
Memantine—CYP2B6—Biological oxidations—POMC—multiple sclerosis	6.14e-05	0.000838	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—MAPK1—multiple sclerosis	6.12e-05	0.000836	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—TYK2—multiple sclerosis	6.09e-05	0.000831	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CCR1—multiple sclerosis	6.01e-05	0.00082	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CXCL13—multiple sclerosis	6.01e-05	0.00082	CbGpPWpGaD
Memantine—Vomiting—Methotrexate—multiple sclerosis	5.99e-05	0.000172	CcSEcCtD
Memantine—GRIN2B—Neuronal System—MAPK1—multiple sclerosis	5.97e-05	0.000815	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—GPR65—multiple sclerosis	5.96e-05	0.000814	CbGpPWpGaD
Memantine—Rash—Methotrexate—multiple sclerosis	5.94e-05	0.00017	CcSEcCtD
Memantine—GRIN2B—Developmental Biology—TYK2—multiple sclerosis	5.94e-05	0.00081	CbGpPWpGaD
Memantine—Dermatitis—Methotrexate—multiple sclerosis	5.93e-05	0.00017	CcSEcCtD
Memantine—Headache—Methotrexate—multiple sclerosis	5.9e-05	0.000169	CcSEcCtD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	5.8e-05	0.000791	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP27B1—multiple sclerosis	5.78e-05	0.00079	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—CYP24A1—multiple sclerosis	5.78e-05	0.00079	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—LINGO1—multiple sclerosis	5.77e-05	0.000787	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GPC5—multiple sclerosis	5.76e-05	0.000787	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—POMC—multiple sclerosis	5.7e-05	0.000778	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CXCL10—multiple sclerosis	5.69e-05	0.000777	CbGpPWpGaD
Memantine—Nausea—Methotrexate—multiple sclerosis	5.59e-05	0.00016	CcSEcCtD
Memantine—DRD2—Signaling by GPCR—CXCL13—multiple sclerosis	5.45e-05	0.000745	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CCR1—multiple sclerosis	5.45e-05	0.000745	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—MAPK1—multiple sclerosis	5.43e-05	0.000742	CbGpPWpGaD
Memantine—SLC22A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	5.43e-05	0.000741	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—MAPK1—multiple sclerosis	5.29e-05	0.000723	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GPC5—multiple sclerosis	5.29e-05	0.000722	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SRM—multiple sclerosis	5e-05	0.000683	CbGpPWpGaD
Memantine—CYP2A6—NRF2 pathway—TGFB1—multiple sclerosis	5e-05	0.000683	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TAGAP—multiple sclerosis	5e-05	0.000683	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CCL5—multiple sclerosis	4.9e-05	0.000669	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—MMP9—multiple sclerosis	4.8e-05	0.000655	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—RRM1—multiple sclerosis	4.77e-05	0.000652	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—MMP9—multiple sclerosis	4.67e-05	0.000638	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	4.67e-05	0.000637	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	4.67e-05	0.000637	CbGpPWpGaD
Memantine—CYP2C19—Biological oxidations—POMC—multiple sclerosis	4.64e-05	0.000633	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	4.53e-05	0.000619	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	4.43e-05	0.000605	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CCR5—multiple sclerosis	4.41e-05	0.000603	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—RRM1—multiple sclerosis	4.38e-05	0.000598	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—S1PR1—multiple sclerosis	4.37e-05	0.000597	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GPC5—multiple sclerosis	4.27e-05	0.000583	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—STAT3—multiple sclerosis	4.26e-05	0.000582	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GPC5—multiple sclerosis	4.25e-05	0.000581	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—IL6—multiple sclerosis	4.17e-05	0.00057	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—STAT3—multiple sclerosis	4.16e-05	0.000568	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	4.15e-05	0.000567	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—PTGER4—multiple sclerosis	4.12e-05	0.000563	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—IL6—multiple sclerosis	4.07e-05	0.000555	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CXCR3—multiple sclerosis	3.98e-05	0.000543	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—TGFB1—multiple sclerosis	3.95e-05	0.00054	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CCL3—multiple sclerosis	3.89e-05	0.000531	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—MAPK1—multiple sclerosis	3.88e-05	0.000529	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CCR2—multiple sclerosis	3.87e-05	0.000529	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—TGFB1—multiple sclerosis	3.85e-05	0.000526	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—MAPK1—multiple sclerosis	3.78e-05	0.000516	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PTGER4—multiple sclerosis	3.74e-05	0.000511	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—RGS1—multiple sclerosis	3.72e-05	0.000507	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—TNF—multiple sclerosis	3.69e-05	0.000504	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CXCR3—multiple sclerosis	3.61e-05	0.000493	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—TNF—multiple sclerosis	3.6e-05	0.000491	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CNR1—multiple sclerosis	3.57e-05	0.000488	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—RRM1—multiple sclerosis	3.54e-05	0.000483	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	3.53e-05	0.000481	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	3.53e-05	0.000481	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GPR65—multiple sclerosis	3.52e-05	0.000481	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CCR2—multiple sclerosis	3.51e-05	0.00048	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—POMC—multiple sclerosis	3.45e-05	0.000471	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.45e-05	0.000471	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CCL2—multiple sclerosis	3.38e-05	0.000461	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CNR1—multiple sclerosis	3.24e-05	0.000443	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GPC5—multiple sclerosis	3.22e-05	0.00044	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCR1—multiple sclerosis	3.22e-05	0.00044	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CXCL13—multiple sclerosis	3.22e-05	0.00044	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CXCL10—multiple sclerosis	3.22e-05	0.000439	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—MAPK1—multiple sclerosis	3.18e-05	0.000435	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—IL6—multiple sclerosis	2.98e-05	0.000407	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CXCL10—multiple sclerosis	2.92e-05	0.000399	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—IL6—multiple sclerosis	2.9e-05	0.000396	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—IL6—multiple sclerosis	2.81e-05	0.000383	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CCL5—multiple sclerosis	2.77e-05	0.000378	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.76e-05	0.000377	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—BCHE—multiple sclerosis	2.74e-05	0.000374	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.67e-05	0.000365	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—BCHE—multiple sclerosis	2.52e-05	0.000344	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CCL5—multiple sclerosis	2.51e-05	0.000343	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—CCR5—multiple sclerosis	2.49e-05	0.000341	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—IL2RA—multiple sclerosis	2.46e-05	0.000336	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCL3—multiple sclerosis	2.3e-05	0.000314	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CCR5—multiple sclerosis	2.26e-05	0.000309	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL2RA—multiple sclerosis	2.23e-05	0.000305	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTGER4—multiple sclerosis	2.21e-05	0.000302	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PGR—multiple sclerosis	2.18e-05	0.000297	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CXCR3—multiple sclerosis	2.13e-05	0.000291	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CD28—multiple sclerosis	2.11e-05	0.000289	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCR2—multiple sclerosis	2.08e-05	0.000284	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.07e-05	0.000283	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—BCHE—multiple sclerosis	2.03e-05	0.000277	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—POMC—multiple sclerosis	1.95e-05	0.000266	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CNR1—multiple sclerosis	1.92e-05	0.000262	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.78e-05	0.000243	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—POMC—multiple sclerosis	1.77e-05	0.000242	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—CCL2—multiple sclerosis	1.73e-05	0.000237	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CXCL10—multiple sclerosis	1.73e-05	0.000236	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—APOE—multiple sclerosis	1.65e-05	0.000225	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.62e-05	0.000222	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—TYK2—multiple sclerosis	1.57e-05	0.000215	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.53e-05	0.00021	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—APOE—multiple sclerosis	1.51e-05	0.000207	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CD86—multiple sclerosis	1.51e-05	0.000206	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCL5—multiple sclerosis	1.49e-05	0.000203	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—IL2—multiple sclerosis	1.44e-05	0.000197	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—POMC—multiple sclerosis	1.42e-05	0.000193	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SPP1—multiple sclerosis	1.38e-05	0.000188	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCR5—multiple sclerosis	1.34e-05	0.000183	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL2RA—multiple sclerosis	1.32e-05	0.00018	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL2—multiple sclerosis	1.31e-05	0.000179	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—POMC—multiple sclerosis	1.3e-05	0.000178	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ALB—multiple sclerosis	1.29e-05	0.000176	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—APOE—multiple sclerosis	1.22e-05	0.000167	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—APOE—multiple sclerosis	1.22e-05	0.000166	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ALB—multiple sclerosis	1.19e-05	0.000162	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CD80—multiple sclerosis	1.1e-05	0.00015	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—POMC—multiple sclerosis	1.05e-05	0.000143	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—POMC—multiple sclerosis	1.05e-05	0.000143	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CCL2—multiple sclerosis	1.02e-05	0.00014	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—MAPK1—multiple sclerosis	1e-05	0.000137	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ALB—multiple sclerosis	9.57e-06	0.000131	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TYK2—multiple sclerosis	9.29e-06	0.000127	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—APOE—multiple sclerosis	9.23e-06	0.000126	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—POMC—multiple sclerosis	7.93e-06	0.000108	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL2—multiple sclerosis	7.73e-06	0.000106	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—IL6—multiple sclerosis	7.69e-06	0.000105	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MMP9—multiple sclerosis	7.32e-06	9.99e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ALB—multiple sclerosis	7.23e-06	9.87e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—STAT3—multiple sclerosis	6.51e-06	8.88e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MYC—multiple sclerosis	6.04e-06	8.25e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TGFB1—multiple sclerosis	6.03e-06	8.23e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MAPK1—multiple sclerosis	5.91e-06	8.07e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IL6—multiple sclerosis	4.54e-06	6.2e-05	CbGpPWpGaD
